Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients
Levi B. Richards, Job J.M.H. van Bragt, Reim Aarab, Cristina Longo, Anne H. Neerincx, Jaap K. Sont, Els J.M. Weersink, Gert‐Jan Braunstahl, Anneke Ten Brinke, Elisabeth H. Bel, Anke H. Maitland‐van der Zee
Topics & Concepts
MepolizumabMedicineAsthmaPrednisonePopulationDoseClinical trialInclusion and exclusion criteriaPediatricsInternal medicineRandomized controlled trialPhysical therapyEosinophilAlternative medicinePathologyEnvironmental healthAsthma and respiratory diseasesDelphi Technique in ResearchIL-33, ST2, and ILC Pathways